HUTCHMED China’s Director Holds 16,000 Shares Amid Tazverik Recall, Signaling Steady Confidence in Long‑Term Growth
Insider holdings at HUTCHMED China show confidence amid a Tazverik recall, signalling long‑term commitment and potential rebound prospects.
3 minutes to read